Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116280993 | 11628099 | 3 | F | 20160712 | 20151014 | 20160715 | EXP | CA-AMGEN-CANSP2015106439 | AMGEN | 60.00 | YR | A | F | Y | 0.00000 | 20160715 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116280993 | 11628099 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 116280993 | 11628099 | 2 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Unknown | 0 | TABLET | ||||||||||
| 116280993 | 11628099 | 3 | SS | MOBICOX | MELOXICAM | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 116280993 | 11628099 | 4 | SS | CYTOTEC | MISOPROSTOL | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 116280993 | 11628099 | 5 | SS | DICLOFENAC | DICLOFENAC | 1 | Unknown | UNK | 0 | ||||||||||
| 116280993 | 11628099 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 116280993 | 11628099 | 7 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 116280993 | 11628099 | 8 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | UNK | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116280993 | 11628099 | 1 | Rheumatoid arthritis |
| 116280993 | 11628099 | 2 | Product used for unknown indication |
| 116280993 | 11628099 | 3 | Product used for unknown indication |
| 116280993 | 11628099 | 4 | Product used for unknown indication |
| 116280993 | 11628099 | 5 | Product used for unknown indication |
| 116280993 | 11628099 | 6 | Rheumatoid arthritis |
| 116280993 | 11628099 | 7 | Rheumatoid arthritis |
| 116280993 | 11628099 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116280993 | 11628099 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116280993 | 11628099 | Abdominal discomfort | |
| 116280993 | 11628099 | Arthropathy | |
| 116280993 | 11628099 | Condition aggravated | |
| 116280993 | 11628099 | Diabetes mellitus | |
| 116280993 | 11628099 | Drug hypersensitivity | |
| 116280993 | 11628099 | Drug ineffective | |
| 116280993 | 11628099 | Headache | |
| 116280993 | 11628099 | Joint swelling | |
| 116280993 | 11628099 | Mass | |
| 116280993 | 11628099 | Pruritus | |
| 116280993 | 11628099 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116280993 | 11628099 | 1 | 2002 | 0 | ||
| 116280993 | 11628099 | 8 | 201305 | 0 |